Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

PEB regimen

View Patient Information

A chemotherapy regimen consisting of bleomycin, etoposide and cisplatin used for the treatment of pediatric germ cell tumors (GCT). In the PEB regimen, the pediatric patients receive bleomycin once per cycle and do not receive weekly bleomycin during the weeks between cycles (every 21 days); in the adult BEP regimen, patients receive weekly bleomycin.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	cisplatin-etoposide-bleomycin regimen cisplatin/etoposide/bleomycin pediatric BEP regimen pediatric PEB platinol-etoposide-bleomycin regimen
Abbreviation:	PEB

PEB regimen

Search NCI's Drug Dictionary